1-4 of 4
Jianfang Zeng
Close
Sort by
Journal Articles

Targeting Misfolded p53 and p53 Aggregation to Overcome Resistance to Apoptosis in Acute Myeloid Leukemia

Michael Andreeff, MD PhD, Jianfang Zeng, MD, Alice Soragni, PhD, Vivian Ruvolo, Bing Z Carter, PhD, Jo Ishizawa, MD PhD, Jared K. Burks, PhD, David Eisenberg, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3786.
https://doi.org/10.1182/blood-2019-130900
Published: 2019
Journal Articles

Targeting Aggregation of Wilde-Type p53 and Mutant p53 with ReACp53 As a Novel Therapeutic Concept for AML

Jianfang Zeng, MD PhD, Alice Soragni, PhD, Jo Ishizawa, MDPhD, Vivian Ruvolo, MS, Christopher B. Benton, MD, Teresa McQueen, MS, Peter Ruvolo, PhD, Yuan Qi, PhD, Xiaoping Su, PhD, Jared Burks, PhD, David S. Eisenberg, PhD, Michael Andreeff, MD PhD
Journal: Blood
Blood (2016) 128 (22): 3944.
https://doi.org/10.1182/blood.V128.22.3944.3944
Published: 2016
Journal Articles

ONC212 Is a Potent Member of the Imipridone Class of Anti-Cancer Compounds That Induces p53-Independent Apoptosis in Hematological Malignancies

Takenobu Nii, PhD, Jo Ishizawa, MD PhD, Ran Zhao, Jianfang Zeng, MD PhD, Dhruv Chachad, Kensuke Kojima, MD PhD, Marina Konopleva, MD PhD, Richard Eric Davis, MD, Joshua E Allen, PhD, Martin Stogniew, PhD, Michael Andreeff, MD PhD
Journal: Blood
Blood (2016) 128 (22): 4059.
https://doi.org/10.1182/blood.V128.22.4059.4059
Published: 2016
Journal Articles

Tyrosine kinase inhibitors induce mesenchymal stem cell–mediated resistance in BCR-ABL + acute lymphoblastic leukemia

Brief Report
Saradhi Mallampati, Xiaohong Leng, Haiqing Ma, Jianfang Zeng, June Li, Haiying Wang, Kevin Lin, Yue Lu, Yang Yang, Baohua Sun, Yun Gong, Ju-Seog Lee, Marina Konopleva, Michael Andreeff, Ralph B. Arlinghaus, Zhen Cai, Bingliang Fang, Haifa Shen, Xin Han, Cheryl F. Hirsch-Ginsberg, Xiaolian Gao, Anurag N. Paranjape, Sendurai A. Mani, Karen Clise-Dwyer, Xiaoping Sun
Journal: Blood
Blood (2015) 125 (19): 2968–2973.
https://doi.org/10.1182/blood-2014-05-576421
Published: 2015
Includes: Supplemental data